Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Charco Neurotech

Request full access

Wearable vibrotactile device for Parkinson's symptom relief

Cambridge, United KingdomFounded 2019Health Tech & Medtech

About Charco Neurotech

Charco Neurotech, founded in Cambridge, UK, in 2019 by CEO Lucy Jung, is a medical technology company focused on improving the quality of life for people with Parkinson's disease. The company's creation was inspired by Jung's encounter with an individual with Parkinson's who had lost the ability to smile and by the 19th-century observations of neurologist Jean-Martin Charcot on the therapeutic effects of vibrations.

The company develops the CUE1, a non-invasive, wearable medical device that adheres to the sternum. It utilizes focused vibrotactile stimulation and rhythmic cueing to alleviate motor symptoms such as slowness, stiffness, and freezing of gait. The technology is designed to modulate overactive brainwaves that cause many Parkinson's symptoms and provide an external stimulus to help initiate movement. An accompanying app allows users to track their symptoms, quality of life measures, and set medication reminders.

Charco Neurotech operates on a direct-to-consumer (B2C) business model and is expanding into healthcare systems, with approvals for sale on the NHS in the UK and regulatory approval in Europe. The company has raised a total of $17.7M in funding over six rounds, including a significant $10 million seed round in 2021 co-led by Amadeus Capital Partners and Parkwalk Advisors. This funding supports product rollout, team expansion, and manufacturing processes. The company has established a strategic partnership with the European Parkinson's Disease Association to increase the availability of its solutions.

Source: Dealroom company data

Charco Neurotech in the Cambridge ecosystem

Live from Dealroom

The Charco Neurotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

  • Imperial College Enterprise Fund
  • Crista Galli Ventures
  • Keith Gibbs
  • Parkwalk Advisors
  • Mint Venture Partners
  • UTEC - The University of Tokyo Edge Capital Partners
  • Amadeus Capital Partners
  • Innovate UK Business Connect
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Charco Neurotech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.